07.02.14
New Brunswick, NJ
732.524.0400
www.jnj.com
Sales: $7.6 billion for baby, oral and skin care products. Corporate sales: $71.3 billion.
Key Personnel: Alex Gorsky, chairman and chief executive officer; Sandra E. Peterson, group worldwide chairman; Lynn Pendergrass, worldwide chairman, consumer; Paulus Stoffels, M.D., chief scientific officer; Michael H. Ullmann, VP-general counsel; Dominic J. Caruso, VP-finance and chief financial officer; Peter M. Fasolo, VP-global human resources.
Major Products: Listerine oral care, Johnson’s Baby personal care, and Neutrogena and Aveeno skin care products.
New Products: Aveeno—Positively Radiant Targeted Tone Corrector and Makeup Removing Wipes, and Clear Complexion BB Cream Broad Spectrum SPF 30; Listerine—Naturals Clean and Ultraclean; Neutrogena—Nourishing Long Wear Liquid Makeup, Beach Defense Sunscreen Stick, Rapid Tone Repair Dark Spot Corrector, Visibly Even BB Cream, Triple Repair Shampoo.
Comments: While corporate sales were up 6.1%, sales of products in Happi’s field rose less than 3% last year. Skin care sales increased 2.4% to $3.7 billion, thanks to strong results from the Neutrogena, Aveeno and Dabao brands. Baby care sales were up 1.8% to nearly $2.3 billion, on the strength of hair care and baby cleanser sales outside the US, as well as the sale of products from Shanghai Elsker Mother & Baby Co., Ltd., a well-regarded Chinese baby care brand J&J acquired last year. However, oral care was essentially flat at $1.6 billion, as increased sales of Listerine outside the US were partially offset by lower toothbrush sales.
In January, J&J announced that it had removed formaldehyde from its baby shampoo and plans to remove the material from its entire product line by 2015.
For the first quarter of 2014, consumer product sales fell 3.2% to $3.6 billion; but Aveeno and Dabao skin care sales rose.
732.524.0400
www.jnj.com
Sales: $7.6 billion for baby, oral and skin care products. Corporate sales: $71.3 billion.
Key Personnel: Alex Gorsky, chairman and chief executive officer; Sandra E. Peterson, group worldwide chairman; Lynn Pendergrass, worldwide chairman, consumer; Paulus Stoffels, M.D., chief scientific officer; Michael H. Ullmann, VP-general counsel; Dominic J. Caruso, VP-finance and chief financial officer; Peter M. Fasolo, VP-global human resources.
Major Products: Listerine oral care, Johnson’s Baby personal care, and Neutrogena and Aveeno skin care products.
New Products: Aveeno—Positively Radiant Targeted Tone Corrector and Makeup Removing Wipes, and Clear Complexion BB Cream Broad Spectrum SPF 30; Listerine—Naturals Clean and Ultraclean; Neutrogena—Nourishing Long Wear Liquid Makeup, Beach Defense Sunscreen Stick, Rapid Tone Repair Dark Spot Corrector, Visibly Even BB Cream, Triple Repair Shampoo.
Comments: While corporate sales were up 6.1%, sales of products in Happi’s field rose less than 3% last year. Skin care sales increased 2.4% to $3.7 billion, thanks to strong results from the Neutrogena, Aveeno and Dabao brands. Baby care sales were up 1.8% to nearly $2.3 billion, on the strength of hair care and baby cleanser sales outside the US, as well as the sale of products from Shanghai Elsker Mother & Baby Co., Ltd., a well-regarded Chinese baby care brand J&J acquired last year. However, oral care was essentially flat at $1.6 billion, as increased sales of Listerine outside the US were partially offset by lower toothbrush sales.
In January, J&J announced that it had removed formaldehyde from its baby shampoo and plans to remove the material from its entire product line by 2015.
For the first quarter of 2014, consumer product sales fell 3.2% to $3.6 billion; but Aveeno and Dabao skin care sales rose.
